Animal Intestinal Health Market : Global Industry Analysis and Opportunity Assessment, 2035

Animal Intestinal Health Market Size and Share Forecast Outlook From 2025 to 2035

The global animal intestinal health market is valued at USD 1.6 billion in 2025 and is slated to reach USD 2.2 billion by 2035, which shows a CAGR of 3.5%.

Quick Stats for Animal Intestinal Health Market

• Market Value (2025): USD 1.6 billion
• Forecast Value (2035): USD 2.2 billion
• Forecast CAGR: 3.5%
• Form Leader in 2025: Powder (50% Market Share)
• Top Function Channel: Digestive Health (45% Market Share in 2025)
• Key Growth Region: North America (USA is the fastest-growing market with 6.0% CAGR)

Metric	Value
2025 Market Size	USD 1.6 billion
2035 Market Size	USD 2.2 billion
CAGR (2025 to 2035)	3.5%

Growth will be driven by rising awareness regarding digestive health, reduced antibiotic use, and the integration of natural feed additives including probiotics, prebiotics, and postbiotics. Additionally, early-life nutritional interventions and the increasing use of lactic acid bacteria to stabilize gut microbiota are expected to accelerate market expansion.

The USA is projected to grow at a CAGR of 6.0% through 2035, driven by advanced feed additive technologies and regulatory support. Germany follows with a CAGR of 5.0%, supported by its robust livestock sector and probiotic adoption, while France records a CAGR of 4.6% due to high dairy and poultry production.

In terms of segments, poultry leads the animal type category with a 35% market share in 2025, driven by demand for efficient feed conversion. Prebiotics dominate the ingredient type segment, holding a 40% share due to their gut microbiota enhancement benefits.

In recent years, companies have driven major innovations to enhance animal intestinal health by focusing on precision nutrition and microbiome modulation. Evonik and Vland Biotech formed a joint venture in China to develop advanced probiotics that improve gut health in farm animals and replace antimicrobial growth promoters. In September, Boehringer Ingelheim acquired Saiba Animal Health AG to expand its pet digestive health portfolio and strengthen R&D capabilities.

Governments worldwide are reducing antibiotic use in animal feed to combat antimicrobial resistance. The European Union enforces strict bans on antibiotic growth promoters, while China promotes traditional herbal additives and microbiome-enhancing solutions in livestock.

The animal intestinal health market represents a niche segment within the broader animal nutrition market, which is part of the food and beverage industry. While its direct share in global food and beverage or chemicals markets is minimal, within animal nutrition, it accounts for approximately 10-15%, driven by rising demand for digestive health solutions in livestock and pets. When compared to the overall food and beverage market, its contribution remains below 1%, reflecting its specialized focus.

Animal Intestinal Health Market by Top Investment Segments

The animal intestinal health market segments include animal type, ingredient type, function, form, sales channel, and region. The animal type segment covers cattle, swine, poultry, canine, feline, equine, and others (fish, rabbits, sheep, goats, aquaculture). The ingredient type segment includes prebiotics, postbiotics, phytogenics, and enzymes.

The function segment comprises performance enhancers, weight management, digestive health, and immune boosters. The form segment includes powder, liquid, and tablets. The sales channel segment consists of veterinary hospitals or clinics, e-commerce or internet platforms, specialty stores, animal farms, modern trade, and retail pharmacies or supermarkets. The regional segment includes North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa.

Poultry to Lead the Animal Type Segment with Over 35% Market Share in 2025

Poultry remains the most lucrative segment in the animal intestinal health market, holding a 35% share due to its critical role in global protein supply.

• Producers invest in probiotics, prebiotics, and enzymes to enhance gut health, improve nutrient absorption, and optimize feed conversion ratios, which directly increases growth rates and production efficiency.
• Rising demand for antibiotic-free poultry products also drives the use of natural gut health solutions to maintain flock health and reduce disease risks.

Prebiotics to Lead the Ingredients Type Segment with Nearly 40% Market Share in 2025

Prebiotics lead the ingredients type segment with nearly 40% market share, driven by their widespread use in enhancing gut microbiota balance and overall digestive health in livestock and pets.

• Producers incorporate prebiotics such as inulin and fructooligosaccharides into animal feed to stimulate the growth of beneficial bacteria like lactobacillus and bifidobacterium.
• Their inclusion reduces reliance on antibiotics, aligning with global regulatory trends promoting natural alternatives.

Digestive Health to Lead the Function Segment with Over 45% Market Share in 2025

Digestive health dominates the function segment with a 45% market share, as it addresses core animal productivity and welfare needs.

• Producers integrate probiotics, prebiotics, and enzymes into feed formulations to enhance nutrient absorption.
• This function remains critical in poultry, swine, and cattle sectors, where optimal gut health translates into better performance and reduced veterinary costs.

Powder to Lead the Form Segment with 50% Market Share in 2025

Powder formulations lead the form segment with a 50% market share, driven by their widespread use in livestock feed applications due to ease of handling, cost efficiency, and uniform mixing properties.

• Feed manufacturers prefer powders because they blend seamlessly into premixes and bulk feed rations without altering feed texture or palatability.
• Companies continue to develop innovative microencapsulated powder formulations to enhance ingredient stability through feed processing and storage.

Veterinary Hospitals/Clinics to Lead the Sales Channel Segment with 30% Market Share in 2025

Veterinary hospitals/clinics dominate the sales channel segment with a 30% market share, as they remain the primary point for prescribing and distributing animal intestinal health products.

• Veterinarians directly influence purchasing decisions by recommending probiotics, prebiotics, and enzyme supplements for livestock and pets to treat digestive disorders and improve gut health.
• The segment’s growth is supported by rising pet healthcare expenditure and the increasing importance of preventive gut health interventions across livestock sectors.

Analyzing Top Countries Producing and Consuming Animal Intestinal Health Products

The USA leads with the highest CAGR of 6.0%, supported by its robust livestock sector, investments in precision nutrition, and antibiotic-free feed demand. Japan is projected to grow at a 5.2% CAGR, slightly higher than Germany’s 5.0% and France’s 4.6%, reflecting strong demand for premium animal nutrition and advanced feed technologies. The UK shows the slowest growth at 4.8%, driven by regulatory compliance and sustainability initiatives.

The report covers in-depth analysis of 40+ countries; five top-performing OECD countries are highlighted below.

USA Animal Intestinal Health Market Analysis

The USA animal intestinal health products revenue is projected to grow at a CAGR of 6.0% from 2025 to 2035.

• Growing demand for antibiotic-free animal products.
• Strong investments in precision nutrition R&D.
• High adoption of probiotic and prebiotic feed additives.
• Major players like Cargill and Kemin Industries leading innovations.

Animal Intestinal Health Products Demand Analysis in the UK

Sales of animal intestinal health products in the UK are projected to grow at a CAGR of 4.8% from 2025 to 2035.

• Increasing focus on sustainable animal farming practices.
• High regulatory standards promoting natural feed additives.
• Growing demand for prebiotics and phytogenics in livestock diets.
• Key companies like DSM and Zoetis expanding product portfolios.

Animal Intestinal Health Products Demand Analysis in Germany

Animal intestinal health product demand in Germany is projected to grow at a CAGR of 5.0% from 2025 to 2035.

• Strong livestock sector driving feed additive demand.
• High adoption of probiotic and enzyme-based gut health solutions.
• Regulatory focus on reducing antibiotic use in animal feed.
• Companies like Evonik Industries and ADM leading innovations.

Animal Intestinal Health Products Demand Analysis in France

France’s animal intestinal health products revenue is projected to grow at a CAGR of 4.6% from 2025 to 2035.

• High dairy and poultry production driving gut health solutions.
• Rising demand for natural alternatives to antibiotics.
• Government support for sustainable livestock farming.
• Key players like Adisseo and Cargill expanding their presence.

Japan Animal Intestinal Health Market Analysis

Sales of animal intestinal health products in Japan are projected to grow at a CAGR of 5.2% from 2025 to 2035.

• High demand for premium animal nutrition products.
• Advanced feed manufacturing technologies supporting innovation.
• Growing pet population driving digestive health supplement sales.
• Companies like Ajinomoto and DSM investing in R&D expansion.

Leading Animal Intestinal Health Product Manufacturers and Suppliers

The market remains moderately consolidated, with tier-one companies such as Cargill, ADM, DSM, and Kemin Industries holding significant shares due to their extensive global presence, advanced product portfolios, and strong R&D capabilities.

Tier-two players like EW Nutrition, AB Vista, and AdvaCarePharma cater to niche regional demands with targeted gut health solutions. Top companies compete through innovation in probiotic and prebiotic formulations, strategic acquisitions to expand regional reach, partnerships with feed manufacturers, and sustainable product development.

Recent Animal Intestinal Health Industry News

In March 2025, EW Nutrition acquired majority stake in GREEN INNOVATION, a prominent firm in the gut health space to enhance its position.

In September 2024, Cargill announced the acquisition of two USA feed mills to boost its distribution and production capabilities.

Leading Animal Intestinal Health Producers by Market Share

• Cargill
• ADM
• DSM
• Zoetis
• Kemin Industries
• Adisseo
• Kerry Group plc.
• Novozymes A/S
• AB Vista
• AdvaCarePharma
• EW Nutrition
• Alltech
• Boehringer Ingelheim
• Dechra Pharmaceuticals
• Evonik Industries

Animal Intestinal Health Market Report Scope

Report Attributes	Details
Current Total Market Size (2025)	USD 1.6 billion
Projected Market Size (2035)	USD 2.2 billion
CAGR (2025 to 2035)	3.5%
Base Year for Estimation	2024
Historical Period	2020 to 2024
Projections Period	2025 to 2035
Market Analysis Parameters	Revenue in USD billions/Volume in Units
By Animal Type	Cattle, Swine, Poultry, Canine, Feline, Equine, and Others (Fish, Rabbits, Sheep, Goats, Aquaculture)
By Ingredient Type	Prebiotics, Postbiotics, Phytogenics, and Enzymes
By Function	Performance Enhancer, Weight Management, Digestive Health, and Immune Booster
By Form	Powder, Liquid, and Tablets
By Sales Channel	Veterinary Hospitals/Clinics, E-commerce/Internet Platforms, Specialty Stores, Animal Farms, Modern Trade, and Retail Pharmacies/Supermarkets
Regions Covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East & Africa
Countries Covered	United States, Canada, United Kingdom, Germany, France, China, Japan, South Korea, Brazil, Australia
Key Players	Cargill, ADM, DSM, Kemin Industries, Adisseo, Kerry Group plc, Evonik Industries, AB Vista, AdvaCarePharma, EW Nutrition, Alltech, Boehringer Ingelheim, Dechra Pharmaceuticals, Novozymes A/S.
Additional Attributes	Dollar sales by value, market share analysis by region, and country-wise analysis.

Top Segments Studied in the Animal Intestinal Health Market Report

By Animal Type:

As per Animal type, the industry has been categorized into Plant Cattle, Swine, Canine, Feline, Equine, and Others (Fish, Rabbits, Sheep, Goats, Aquaculture, etc).

By Ingredients Type:

As per species, the industry has been categorized into Nutrition, Prebiotics, Postbiotics, Phytogenics, and Enzymes.

By Function:

This segment is further categorized into Performance Enhancer, Weight Management, Digestive Health, and Immune Booster.

By Form:

This segment is further categorized into Powder, Liquid, and Tablets.

By Sales Channel:

Veterinary Hospitals/Clinics, E-commerce / Internet Platforms, Specialty Stores, Animal Farms, Modern Trade, Retail Pharmacies / Supermarkets.

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.